Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedUpdated the site’s release/revision label for the ClinicalTrials.gov page from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.5.2 added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a resources section linking to the Genetic and Rare Diseases Information Center and included 'Small cell lung carcinoma' as a related term on the page.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision: v3.5.0 has been applied, replacing v3.4.3. This appears to be a general site version upgrade rather than changes to study data or page content.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check91 days agoChange DetectedSite revision updated to v3.4.2; funding-status notice (v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.